Controlled Human Malaria Infection Transmission Model - Phase A

Condition:   Malaria,Falciparum Interventions:   Biological: PfSPZ Challenge;   Drug: Sulfadoxine-Pyrimethamine;   Drug: Piperaquine;   Drug: Artemether lumefantrine;   Drug: Primaquine Sponsors:   University of Oxford;   KEMRI-Wellcome Trust Collaborative Research Program;   Sanaria Inc.;   University Hospital Heidelberg;   Kenya Medical Research Institute Not yet recruiting

Source: ClinicalTrials.gov - February 21, 2020 Category: Research Source Type: clinical trials